peroxisome

peroxisome
Name	Peroxisome
Discovered	1954
Location	Cytosol
Function	Oxidative metabolism

peroxisome

Peroxisomes are small, membrane-bound organelles found in the cytoplasm of eukaryotic cells, involved in oxidative metabolism and lipid processing. They were first described in the mid-20th century and have since been studied across model organisms, clinical cohorts, and molecular laboratories linked to institutions like Max Planck Society, National Institutes of Health, and Harvard Medical School. Research on peroxisomes intersects with projects from centers such as European Molecular Biology Laboratory, Wellcome Trust, and collaborations including Human Genome Project contributors.

Overview

Peroxisomes participate in reactive oxygen species handling and lipid metabolism, with roles characterized via studies at University of Oxford, Massachusetts Institute of Technology, and Stanford University laboratories; clinical implications have been explored at Mayo Clinic, Johns Hopkins Hospital, and Boston Children's Hospital. Foundational work connecting peroxisomes to human disease involved clinicians at Great Ormond Street Hospital and researchers publishing in journals associated with Nature Publishing Group, Cell Press, and The Lancet. Major conferences such as meetings organized by the American Society for Cell Biology and European Society for Clinical Investigation have highlighted peroxisome research programs supported by funding agencies including the National Science Foundation and European Research Council.

Structure and Composition

Peroxisomes are bounded by a single phospholipid bilayer and contain enzymes like catalase and oxidases studied in biochemical labs at University of Cambridge, Yale University, and Columbia University. Structural analyses using techniques developed at Max Planck Institute for Biophysical Chemistry, Cold Spring Harbor Laboratory, and Argonne National Laboratory elucidated peroxisomal matrix protein composition with proteomic catalogs compared across datasets from ProteomeXchange Consortium and institutional repositories at Imperial College London. Membrane proteins such as peroxins are encoded by genes discovered by teams at University of California, San Diego and Karolinska Institutet, with sequence annotations contributed to databases maintained by Ensembl and GenBank. High-resolution imaging using instruments from European Synchrotron Radiation Facility and National Center for Microscopy and Imaging Research revealed spatial organization in cell types studied at John Innes Centre and Salk Institute for Biological Studies.

Biogenesis and Dynamics

Peroxisome formation and proliferation were characterized through genetic screens performed in model species handled at Max Planck Institute for Plant Breeding Research, The Scripps Research Institute, and University of Wisconsin–Madison. Studies implicating peroxin proteins referenced work from laboratories funded by Wellcome Trust Sanger Institute and collaborative consortia like those at Cold Spring Harbor Laboratory and European Molecular Biology Laboratory. Mechanisms of membrane biogenesis involve vesicle budding and protein import monitored using methods refined at European Molecular Biology Laboratory (EMBL), with dynamics tracked in live-cell systems by researchers at University of California, Berkeley and Johns Hopkins University. Regulatory pathways intersect with signaling cascades studied at Dana–Farber Cancer Institute and Fred Hutchinson Cancer Center.

Metabolic Functions

Peroxisomes catalyze beta-oxidation of very-long-chain fatty acids and detoxification of hydrogen peroxide via catalase, with metabolic fluxes quantified in metabolic labs at Broad Institute, Max Delbrück Center for Molecular Medicine, and Kobe University. Their role in plasmalogen biosynthesis ties to neurological phenotypes evaluated in clinics such as Sheffield Children's Hospital and research centers including National Institute of Neurological Disorders and Stroke and Institut Pasteur. Biochemical pathways were mapped in collaborations involving University of Toronto, University of Melbourne, and Seoul National University. Interplay with mitochondrial and lysosomal pathways was elucidated in comparative studies published by groups at University College London and Vanderbilt University.

Role in Disease and Disorders

Peroxisomal dysfunction underlies inherited disorders such as Zellweger spectrum disorders and X-linked adrenoleukodystrophy, with clinical genetics programs at Mount Sinai Hospital, University of California, San Francisco, and Children's Hospital of Philadelphia leading diagnosis and management. Treatment research spans gene therapy trials coordinated by institutions like Gene Therapy Institute and pharmaceutical collaborations with companies listed on exchanges such as Nasdaq and supported by regulators including U.S. Food and Drug Administration and European Medicines Agency. Epidemiological studies from centers at Karolinska Institutet and University of Pittsburgh have informed newborn screening programs implemented in regions overseen by ministries analogous to Ministry of Health (United Kingdom) and Centers for Disease Control and Prevention.

Evolution and Comparative Biology

Peroxisomes are present across diverse eukaryotic lineages studied by evolutionary biologists at Smithsonian Institution, American Museum of Natural History, and National Evolutionary Synthesis Center, with comparative genomics performed at J. Craig Venter Institute and European Bioinformatics Institute. Hypotheses about peroxisome origin have been debated in forums involving researchers from Princeton University, University of Chicago, and École Normale Supérieure, comparing organelle features with bacterial endosymbionts cataloged in collections at Natural History Museum, London and phylogenies curated by Tree of Life Web Project. Conservation and divergence of peroxisomal genes are documented in datasets supported by National Center for Biotechnology Information and analytic tools from Rosalind Franklin Institute.

Category:Cellular organelles